CSF1R and early-onset autosomal dominant Alzheimer disease: A more specific approach to test the role of microglia is to deplete microglia using the colony stimulating factor 1 receptor (CSF1R) inhibitor PLX5622, which has been used to test the role of microglia in brain diseases such as Alzheimer’s disease (Spangenberg et al., 2019).